Endovia Health Sciences, Inc. (SBEV-WT) Financial Statements
Endovia Health Sciences, Inc. (SBEV-WT) files with the U.S. Securities and Exchange Commission under CIK 0001553788. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $73.07 thousand
- Net Income
- -$25.23 million
- Total Assets
- $965.69 thousand
- Net Cash from Operations
- -$4.82 million
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Aug 19, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for SBEV-WT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History